ArticleSurgery today2026
Strategic aortic root enlargement for patients with a small aortic annulus in the era of transcatheter aortic valve-in-surgical aortic valve procedures.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV) is central to lifetime aortic stenosis management, making the initial surgery in small annuli increasingly important. In bioprosthetic surgical aortic valve replacement (AVR), surgeons must balance minimally invasive access, avoid prosthesis-patient mismatch, and prepare for future transcatheter reinterventions. We describe a sternum-sparing, minimally invasive AVR program using the Stonehenge technique with a TAV-in-SAV-oriented strategy for annular and root enlargement. Although Y-incision enlargement allows for valve upsizing, the geometry may remain unfavorable without adequate sinotubular junction (STJ) expansion, increasing the risk of sinus sequestration and coronary obstruction despite acceptable virtual valve-to-coronary (VTC) distances. We added STJ enlargement using the roof technique to achieve an en bloc expansion of the annulus, sinuses, STJ, and proximal ascending aorta. CT analyses and simulations showed that prosthesis tilt can shorten the VTC, especially in the right coronary artery (RCA), recreating a high-risk anatomy. STJ enlargement with tilt minimization may improve future TAV-in-SAV feasibility while preserving the surgical AVR benefits.
Indexed as
Identifiers
42566028What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.